Acadian Health, Llc

CLIA Laboratory Citation Details

2
Total Citations
8
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 10D2295058
Address 937 15th Place, Vero Beach, FL, 32960
City Vero Beach
State FL
Zip Code32960

Citation History (2 surveys)

Survey - June 1, 2026

Survey Type: Special

Survey Event ID: 9GLE11

Deficiency Tags: D0000 D2096 D6019 D2016 D6000

Summary:

Summary Statement of Deficiencies D0000 A desk review survey of the laboratory's proficiency test results was performed on 06 /01/2026 for Acadian Health LLC. The laboratory is not in compliance with 42 CFR Part 493, Requirement for Laboratories. The following Conditions were cited: D2016 493.803(a)(b)(c) Condition: Successful Participation D6000 493.1403 Condition: Moderate Complexity Laboratory Director D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on surveyor proficiency testing (PT) desk review, review of the laboratory's Wisconsin State Laboratory of Hygiene (WSLH) PT records and the review of the Centers for Medicare & Medicaid Services (CMS) Casper reports 153 and 155, and Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- email communication with the WSLH PT program, the laboratory failed to successfully participate in the Subspecialty of Routine Chemistry for the analytes of Routine Chemistry, pH blood gas, PO2 blood gas, PCO2 blood gas, Chlorine, Creatinine, Glucose (non-waived), Potassium, Sodium, and Blood Urea Nitrogen (BUN) for 2 out of 2 testing events in 2025. Findings included: Review of the WSLH proficiency testing records and the review of the CMS 153 and 155 reports, on 04/02 /2026 at 11:21 AM, the laboratory had unsatisfactory testing scores for the analytes of Routine Chemistry, pH blood gas, PO2 blood gas, PCO2 blood gas, Chlorine, Creatinine, Glucose (non-waived), Potassium, Sodium, and BUN for 2 out of 2 testing events in 2025 (See D2096). D2096 ROUTINE CHEMISTRY CFR(s): 493.841(f) (f) Failure to achieve satisfactory performance for the same analyte or test in two consecutive testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on surveyor proficiency testing (PT) desk review, review of the laboratory's Wisconsin State Laboratory of Hygiene (WSLH) PT records and the review of the Centers for Medicare & Medicaid Services (CMS) Casper reports 153 and 155, and email communication with the WSLH PT program, the laboratory failed to successfully participate in the Subspecialty of Routine Chemistry for the analytes of Routine Chemistry, pH blood gas, PO2 blood gas, PCO2 blood gas, Chlorine, Creatinine, Glucose (non-waived), Potassium, Sodium, and Blood Urea Nitrogen (BUN) for 2 out of 2 testing events in 2025. Findings included: Review of the laboratory's WSLH PT records review of the CMS CASPER 153 and 155 reports, and email communication with the WSLH PT program, the laboratory failed to successfully participate in the Subspecialty of Routine Chemistry for the analytes of Routine Chemistry, pH blood gas, PO2 blood gas, PCO2 blood gas, Chlorine, Creatinine, Glucose (non-waived), Potassium, Sodium, and BUN for 2 out of 2 testing events in 2025. 1. Event #2 2025 Routine Chemistry- 0% pH blood gas- 0% PO2 blood gas- 0% PCO2 blood gas- 0% Chlorine- 0% Creatinine- 0% Glucose (non- waived)- 0% Potassium- 0% Sodium- 0% BUN- 0% 2. Event #3 2025 Routine Chemistry- 12% pH blood gas- 0% PO2 blood gas- 20% PCO2 blood gas- 0% Chlorine- 0% Creatinine- 0% Glucose (non-waived)- 0% Potassium- 0% Sodium- 0% BUN- 20% D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on surveyor proficiency testing (PT) desk review, review of the laboratory's Wisconsin State Laboratory of Hygiene (WSLH) PT records and the review of the Centers for Medicare & Medicaid Services (CMS) Casper reports 153 and 155, and email communication with the WSLH PT program, the Laboratory Director failed to -- 2 of 3 -- ensure the laboratory performed PT in such a manner as to achieve and maintain satisfactory performance with successful PT in the Subspecialty of Routine Chemistry for the analytes of Routine Chemistry, pH blood gas, PO2 blood gas, PCO2 blood gas, Chlorine, Creatinine, Glucose (non-waived), Potassium, Sodium, and Blood Urea Nitrogen (BUN) for 2 out of 2 testing events in 2025, resulting in non-initial unsuccessful PT occurrence (See D6016). D6019 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(iv) (e)(4)(iv) An approved

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 10, 2024

Survey Type: Standard

Survey Event ID: 054011

Deficiency Tags: D0000 D5481 D5413

Summary:

Summary Statement of Deficiencies D0000 An initial certification survey was conducted on August 26, 2024 to September 10, 2024. Acadian Health LLC clinical laboratory was not in compliance with 42 CFR 493, requirements for clinical laboratories. D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on observation, record review, and interview, the laboratory failed to document the room temperature and humidity where the EPOC test cartridges for the EPOC Blood Analyzer were stored from 01/08/20224 to 08/26/2024. Findings: Review of the EPOC test cartridges showed, the cards storage temperature range was 15 to 30 degrees Celsius. No temperature and humidity logs were available for review. On 08 /26/2024 at 4:25 AM, Testing Personnel KK acknowledged the temperature and humidity of the room where the cartridges were stored was not recorded. D5481 CONTROL PROCEDURES CFR(s): 493.1256(f)(g) (f) Results of control materials must meet the laboratory's and, as applicable, the manufacturer's test system criteria for acceptability before reporting patient test results. (g) The laboratory must document all control procedures performed. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on review of Quality Controls (QC), patient records, and interview, the laboratory ran one of one patient sample when one of two levels of controls (L1, L2) was out between July 18, 2024 and July 27, 2024. Findings: Review of the QC records for the EPOC Blood Analyzer serial number RDR49895 showed on July 18, 2024, L1 was run three times at 7:33 AM, 11:35 AM, and 11:41 AM, and failed all three times. Review of the QC records showed L1 did not pass until July 27, 2024 AT 6:09 AM. Review of the patient record for the EPOC Blood Analyzer serial number RDR49855 showed one patient's sample was run on July 24, 2024 at 3:05 PM. On 08/26/2024 a 4: 00 PM, Testing Personnel H, acknowledged one patient was run when the QC was out. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access